FDA Investigator Kathleen M Jordan
Kathleen M Jordan has conducted inspections on 11 sites in 1 countries as of 18 Jan 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
18 Jan 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Kathleen M Jordan:
Aditi S Thakur,
Alberto A Viciedo,
Alice S Tsao,
Alison N Stieg,
Amy N Chen,
Anne Marie Russell,
Annet R Rajan,
Anthony F Lorenzo,
Anthony W Lee,
Barbara A Gullick,
Bijoy Panicker,
Brooke K Higgins,
Brooke K Seeman,
Carol L Rehkopf,
Carole L Jones,
Chaltu Nwakijra,
Charles Yuanchia Kuo, PhD,
Chiang Syin, PhD,
Christina K Theodorou,
Clarice J Ahn,
Collins,
Cynthia A Harris, MD, RN,
David A Oluwo,
David P Rice, Jr,
Dawn L Wydner,
Derek S Smith, PhD,
Deyaa Shaheen,
Diane T Bargo,
Diane T O'brien,
Donald C Obenhuber, PhD,
Douglas A Campbell,
Dr. Dominick Roselle,
Dr. Roslyn F Powers,
Dr. Yubing Tang,
Dr. Zhihao Qiu (Peter), PhD,
Edmund F Mrak, Jr,
Edward P Potter,
Emest F Bizjak,
Ephrem Hunde, PhD,
Eric L Dong, BS,
Eric Rothschild,
Esaw,
George Pyramides,
Gerald B Seaborn, Jr,
Graeme E Price,
Graeme Price,
Guerlain Ulysse,
Hector Jcolon Torres,
Hongna Wang,
Jaison J Eapen,
James M Mason,
James M Simpson,
James W Leonette,
Jamie D Richardson,
Jamie D Swann,
Janet A Rajan,
Jazmine N Brown,
Jessica Hankins, PhD,
Jessica K Yoon,
John Dan,
John M Gusto,
Jonah S Ufferfilge,
Jonathan W Chapman,
Jose Ohernandez Guzman,
Joseph W Matthews,
Julie M Anbarchian,
Junho Pak,
Karen A Spencer,
Kelly L Anderson,
Kenneth M Gordon,
Kenneth Nieves,
Ko U Min,
Kristina L Conroy,
Lauren N Barber,
Laurissa S Flowers,
Lawrence Harmon, Jr,
LCDR Debra Emerson,
Leiyun Boone, PhD,
Lori S Lawless,
Malgorzata G Norton, PhD,
Marc S Neubauer,
Marcellinus D Dordunoo,
Marcus A Ray,
Margaret M Doherty,
Marion Michaelis,
Marlene G Swider,
Matthew M Henciak,
Megan A Haggerty,
Melissa J Garcia,
Merideth K Rose,
Michael J Vardon,
Michael R Klapal,
Michael Shanks, MS,
Mindy M Chou,
Mohamad A Chahine,
Monica Commerford, PhD,
Nadeem I Chaudhry,
Nailing Zhang,
Nebil A Oumer,
Nicholas A Violand,
Nicole K Trudel,
Nina D Patel,
Nirjal Bhattarai,
Patricia F Hughes, PhD,
Paul L Bellamy,
Pelekakis,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
Qin Xu,
Quyen T Tran,
Rachael O Oyewole,
Rachel C Harrington,
Rebecca Rodriguez,
Regina Gibson Melton,
Robert H Wittorf,
Robert J Martin,
Russell J Glapion,
Saleem A Akhtar,
Samina S Khan,
Samuel Mindaye,
Sean R Marcsisin,
Sena G Dissmeyer,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Simone E Pitts,
Steven P Donald,
Tajah L Blackburn,
Tamara N Champion,
Tamil Arasu, PhD,
Thomas E Friel,
Thuy T Nguyen, LCDR,
Tonia F Bernard,
Toyin B Oladimeji,
Viviana Matta,
Viviana R Ramirez,
Vivin George,
Walter L Fava,
Wanda Y Honeyblue,
Wayne E Seifert,
William A Warnick,
William D Murray,
William H Linkroum,
Yan Wang,
Yvesna C Blaise,
Yvins Dezan,
Zakaria I Ganiyu,
Zhongren Wu
Kathleen M Jordan's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| February, 2020 | FDA 483 | Nutravail LLC - Form 483, 2020-02-06 |
| September, 2021 | FDA 483 | Pharmaceutics International, Inc. - Form 483, 2021-09-29 |
| April, 2021 | EIR | Cangene BioPharma, LLC - EIR, 2021-04-16 |
| September, 2021 | EIR | Pharmaceutics International, Inc. - EIR, 2021-09-29 |
| September, 2021 | EIR | Pharmaceutics International, Inc. - EIR, 2021-09-29 |
| August, 2022 | FDA 483 | ImClone Systems LLC - Form 483, 2022-08-25 |
| September, 2021 | FDA 483 | Pharmaceutics International, Inc. - Form 483, 2021-09-29 |
| January, 2020 | FDA 483 | Bristol-Myers Squibb Company - Form 483, 2020-01-10 |
| December, 2021 | FDA 483 | Valgene Incorporated dba Cape Drugs - Form 483, 2021-12-02 |
| April, 2021 | FDA 483 | Cangene BioPharma, LLC - Form 483, 2021-04-16 |
| January, 2023 | FDA 483 | Modavar Pharmaceuticals, LLC - Form 483, 2023-01-27 |
| September, 2021 | FDA 483 Response | Pharmaceutics International, Inc. - Form 483R, 2021-11-18 |
| April, 2021 | FDA 483 Response | Cangene BioPharma, LLC - Form 483R, 2021-05-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more